Could cannabis unlock a new treatment path for kidney and bowel cancers?

-   ADCY3 is a shared key gene in both kidney and bowel cancer.
    
-   It could be used as a new biomarker to predict patient outcomes and as a potential target for new treatments.
    
-   The drugs dronabinol, rimonabant and cannabidiol, shows promise as a way to target ADCY3.
    
-   This discovery opens new possibilities for better detection and treatment of these hard-to-treat cancers.

Can Cannabis compounds finally offer a smarter way to treat autoimmune diseases?

-   This recent study suggest they just might.
    
-   Cannabinoids can:
    
-   Adjust regulatory T-cells (the immune system’s “brakes”)
    
-   Calm overactive brain immune cells (microglia)
    
-   Help protect the gut and other body linings (epithelial barriers)

Thank you for reading! 

Use Code  "SafeAccess" for $10 off your order!